Pharma Webinars | Pharmaceutical chemistry Webinar|Pharmaceutical Chemistry Conference| Pharmaceutical Chemistry-2020 | Meetings on Pharma Chemistry | Drug Design Conferences | World Pharmaceutical Chemistry Conferences | Medicinal Plants Chemistry Conferences |Top Pharma Conferences 2020 | Pharmaceutical Sciences Meetings | Europe

Theme: Impact of COVID-19 on Advancements in Pharmaceutical Sciences

Pharmaceutical Chemistry-2020

Scientific Program

Renowned Speakers

Catherine GUILLOU
UnversitÃ© de Paris-Saclay
France

Larisa Klapshina
Nizhny Novgorod State University/IOMC RAS
Russia

Fabio Marinelli
University of Lâ€™Aquila
Italy

Francisco Alonso
Universidad de Alicante
Spain

Mark McLaughlin
Merck Sharp & Dohme (MSD) Dept. of Process Research and Development
USA

Dorota Dobler
University of Applied Sciences
Germany

Shira Engelberg
Israel Institute of Technology
Israel

Vasiliki Daikopoulou
R.G.C.C. S.A.
Greece

Fadhil Wasfi
Jordan University of science and Technology
Jordan

Ming-Chao Huang
Taipei Veterans General Hospital
Taiwan

Young Hyo Kim
Inha University College of Medicine
Spain

Vladimir S. Naumenko
Institute of Cytology and Genetics,
Russia

Anas A Salem
Assiut University,
Egypt

CEJ van Rensburg (Connie Medlen)
University of Pretoria
South Africa

Nicki Norris
Symphony Clinical Research,
USA

Ayad Abdul-Ahad
A3 Pharma Counselling Ltd,
UK

AntÃ³nio JosÃ© Ribeiro
University of Coimbra
Portugal

Dagmar Fischer
Friedrich-Schiller University
Germany

Andreas Bernkop-SchnÃ¼rch
ThioMatrix University of Innsbruck
Austria

Raid Alany
Pharmaceutical Development and Technology, School of Life Sciences Pharmacy and Chemistry Kingston University
UK

Peter Krajcsi
Solvo Biotechnology
Hungary

Pharmaceutical Chemistry-2020

Pharmaceutical Chemistry-2020 is a global overview of the theme " Impact of COVID-19 on Advancements in Pharmaceutical Sciences ". It is a pavement for Pharmaceutical Chemistry experts and scientific professionals to explore the research challenges & current trends and unleash advanced strategies in the arena of Pharma and Chemistry research areas. Pharmaceutical Chemistry-2020 is a specially designed cluster webinar and would lay a platform for the interaction among specialists, directors, professors, faculties, experts and research fellows around the world reputed research institutes, universities and companies, agencies, association & societies. It aims in accelerating the scientific discoveries in the field of Pharma and Chemistry to exchange information on their latest research progress. We are glad to have your partcipation in ‘16^th International Conference on Pharmaceutical Chemistry’ to be held during 17-18 August, 2020 (webinar) which was initially scheduled in London, UK. The organizing committee is gearing up for an exciting and informative event procuring plenary lectures, symposium, workshops, Video presentations, poster presentations on a variety of topics and various sessions for participants from all over the world.

For more details please visit- https://pharmaceuticalchemistry.pharmaceuticalconferences.com/

With all the Expert scientific people over the world focused on learning about Pharmaceutical Current and Novel trends and advanced strategies and Technologies emerging in Pharma and Chemistry research areas. This is a best globalised opportunity to reach the largest assemblage of participants from the Pharma and Chemistry community. We anticipate participants, renowned speakers, pharmacists/chemist and eminent delegates across the globe attending the conference to share their valuable presentation and galvanize the scientific community.

Pharmaceutical Chemistry 2020 is a 2-day event offering the Exhibition at venue to showcase the new and emerging technologies and Conduct presentations, distribute information, meet with potential scientists, make a splash with new drug developments, and receive fame and recognition. Our services have always met with great achievement in Business Conferencing. World-renowned speakers, the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Target Audience:

Eminent Scientific Professionals in Pharma and Chemistry
Faculty (Professors, Associate Professors, Asst. Professors)
Pharma and Chemistry Colleges & Training Institutes
Pharmaceutical and Chemistry Associations and Societies
Pharmaceutical Business Entrepreneurs
Manufacturing Pharmaceutical products Companies
Manufacturing Medical Devices Companies
Pharma and Chemistry Students
PhD Scholars, Graduates and Post Graduates
Directors, CEO’s of Organizations
Association, Association presidents and professionals
Noble laureates in Health Care and Medicine
Bio instruments Professionals
Bio-informatics Professionals
Research Institutes and members
CRO and DATA management Companies
Data Management Companies

Track 1: Pharmaceutical Formulations: Academic and Industry Perspective

Increasingly, medicines research is moving from ‘big Pharma’ to small biotech companies and start-ups. To succeed in this new environment, scientific skills are not enough employers and financiers also need to be confident that the people they are working with possess the entrepreneurial skills to grow and sustain a business effectively. Pharmaceutical formulation development enables development of robust and compliant formulations and resolve difficult challenges encountered during preclinical and clinical development.

Pharmaceutics and Drug Delivery
Pre Formulation & Formulation Aspects
Preformulation in Drug Development
Major Challenges in Drug Development

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 2: Pharmaceutical Research and Development

Research and Development can be defined as innovative and experimental work undertaken on a systematic basis to increase the stock of knowledge including search of new molecules, synthesis and modification of known molecules and some methods to increase production rate by adopting diverse techniques. Superior quality R&D work requires an excellent back up from what are called the support functions. These include analytical, information services and technology, intellectual property and regulatory affairs. These are some of the main considerations in Pharmaceutical Technology and for the development of new drug candidates. The management of these functions, especially the laboratory based analytical service, requires many of the skills associated with core R&D and will therefore not be treated separately in any detail, except to point out their relationship and role within the organization.

Challenges in Pharmaceutical Formulations
Scope of Pharmaceutical Research
Pharmaceutical Research & Development
Pharmaceutical Packaging and labeling
Pharmaceutical industry
Bioinformatics and Computational Biology
Pharmaceutical Technology Assessment
Quality assurance
Opportunities in Pharmaceutical Management
Pharmaceutical Chemistry
Ethnopharmacology

Track 3: Chemo genomics

Chemogenomics is an emergent discipline that combines the latest tools of genomics and chemistry and applies in the discovery of novel drug molecules thereby to target drug discovery. Because of the almost infinite number of drug-like organic molecules, this is an impossible task. Chemogenomics, on the other hand can be defined as the investigation of classes of compounds or related libraries. These compounds are meant to work against families of functionally related proteins in the protein structure. Chemogenomics also deals with the chemical-biological interactions and their systematic analysis. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

Biomolecules
Preparation of Natural products
Metal Complexes creation
Asymmetric synthesis
Organometallic chemistry
Nucleotide chemistry
Chemogenomics and Chemical Biology for Target Identification and Validation
Assemblies of macrolide-mimetics
Spiro– medium- and large(macro) heterocyclic systems
Isosteric replacements of amino acids, di-/tri-peptides

Track 4: Solid-state pharmaceutical chemistry

Solid-state pharmaceutical chemistry envelops a wide scope of concentrates on pharmaceutical solids including (1) assurance of the physical properties of polymorphs and solvates, (2) physical changes among polymorphs and solvates, (3) chemical responses in the solid state, and (4) solid-solid responses which happen in pharmaceutical preparations. Recent advances in this field incorporate improved comprehension of crystallization processes, improved comprehension of the requirement for characterization of polymorphs and solvates for both control and administrative purposes, and a superior comprehension of the mechanisms of solid state degradations and solid-solid reactions.

Track 5: Pharmaceutical Organic Chemistry

Organic chemistry is the scientific study of the structure, properties, composition, reactions, and synthesis of organic compounds that by definition contain carbon. Organic chemistry is the scientific study of the structure, properties, composition, reactions, and synthesis of organic compounds that by definition contain carbon. Pharmaceutical heavily relies on medical world as it centers around medicine and other health related compound. A pharmacist should have sufficient knowledge of organic chemistry as the basis of drug prescription.

Track 6: Pharmacovigilance

Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established its Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961. Together with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, WHO promotes PV at the country level. At the end of 2010, 134 countries were part of the WHO PV Programme. The aims of PV are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.

Track 7: Drug Discovery Chemistry

The discovery of candidate drug targets is challenging, requiring the rapid development of techniques to identify the difference genomic profiling in disease and normal conditions, which will facilitate the understanding of the disease mechanism and the development of potential drugs for disease treatment. Medicinal chemistry has increasingly employed microarrays to identify both key target genes and gene networks that can regulate the effectiveness of drugs. As compared with all the other phases in drug discovery, this stage is complex by the fact that the identified drug target must mollify a variety of standards to permit development to the next step. For example, the target must be selectively present in the pathogen, i.e. medicinal chemistry along with coding genes of drug design target that are preserved across different pathogens and have no human homologs and therefore they represent striking target candidates for new broad-spectrum drugs. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

Fragment-Based Drug Discovery
Macrocyclics & Constrained Peptides
Biophysical Approaches for Drug Discovery
Small Molecules for Cancer Immunotherapy
Inflammation Inhibitors
Protein-Protein Interactions
GPCR-Targeted Drug Design
Blood-Brain Penetrate Inhibitors
Kinase Inhibitor Chemistry

Track 8: Medicinal Chemistry Strategies

In the drug discovery and drug development of a new drug, different terms are assigned to the substances that are studied at different steps in the process. Only if a substance fulfils the requirements for a certain level is it subjected to testing on the next level. The process starts with a compound which is a chemical substance of defined chemical structure and purity. There are many strategies developed in Medicinal Chemistry in the recent years for the development of new drug candidates. Compounds that show specific binding properties and are active are referred to as ‘hits’ and are further validated; this includes verifying their chemical identity and purity and determining their binding properties in one or more secondary assays. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

ADCs – Targeted delivery
Immuno-oncology
Small-molecule targeting of RNAs
Preventative Toxicology
Molecules with predictable in vivo and safety profiles
Phenotypic screening
SBDD Case studies
Macrocyclic compounds

Track 9: Pharma Medicinal Chemistry

Modern drug research and development (R&D) has experienced remarkable changes as technological and scientific developments in the past years have dramatically changed the pharmaceutical innovation process. Well-established strategies, such as high-throughput screening (HTS), have progressively been applied in association with novel techniques founded on genomics, molecular and structural biology and molecular modeling.

Targeted protein degradation / PROTACs
DNA Encoded Libraries
Hit-to-Lead Optimization
Predictive Toxicology – Improving Compound Safety
Optimizing Outsourcing Activities
Artificial Intelligence in Medicinal Chemistry

Track 10: Integrating Medicinal Chemistry into the Drug Discovery Process

Traditionally, “drug delivery” was a specialization in pharmacy for formulations of drugs. However, it is natural that organic, medicinal, materials, and nano chemistry have now become deeply involved in the development of drug delivery systems. These approaches have led to the creation of drug conjugates that are new chemical entities. The use of functional carbon nanotubes as well as designed polymers as a vehicle for drug delivery is a novel approach to drug discovery. Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs). The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

Drug Discovery Chemistry – where are we heading
Target Validation using Medicinal Chemistry tools
Optimizing hit to lead optimization quality and timescale
Best Practice Case Studies
Data for decision making
Protein Degradation Strategies
Future of Medicinal Chemistry

Track 11: Pharmacokinetics and Pharmacodynamics in Drugs

Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics include enhancing efficacy and decreasing toxicity of a patient’s drug therapy. The development of strong correlations between drug concentrations and their pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.

Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and adverse effects. The effect of a drug present at the site of action is determined by that drug’s binding with a receptor.

Pharmacokinetic parameters
Pharmacodynamic parameters
Absorption of drugs
Distribution of drugs
Biotransformation/metabolism
Excretion of drugs
Pharmacodynamics

Track 12: Drug Design and Synthesis

The rational development of new drugs is a complex process involving a myriad of different disciplines. In nearly all of these, computational tools serve to guide the design decisions, ultimately speeding up and reducing the cost of development. Drug design and the synthesis of new drug molecules is one of the important aspect in medicinal chemistry and it is one of the keytopics discussed at Medicinal Chemistry Conferences. In the area of medicinal chemistry, computational methods are applied both to identify new starting points and to guide the further development of promising substances.

Frontiers in Catalysis
Aggressive Bond Disconnections in Total Synthesis
Chemical Probes for Characterizing Biology
Synthetic Biology for Natural Products
Advances in Drug Discovery
Natural Product Discovery and Biosynthesis
Combining Synthesis and Biosynthesis to Construct Complex Molecules
New Directions in Antibiotic Discovery and Development
Accessing Complex Molecules
Structure-biodegradability relationship
Diversity-Oriented Synthesis

Track 13: Organic Chemistry

The synthesis of each molecule was first carried out on a small scale (probably milligrams) in the laboratory, followed much later by development of safe, efficient, and scalable methods to provide kilograms of active pharmaceutical ingredient (API) that was incorporated into dosage forms for administration to patients. It is critical to point out that an early step in the complex process of drug discovery was the synthesis of a molecule that tested a hypothesis faced by the project team. This required a medicinal chemist to use organic chemistry training and experience to conceive of a compound and then employ appropriate reactions to furnish the desired target and synthesize a suitable number of derivatives to optimize the spectrum of properties associated with drug like candidates. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

Medicinal chemistry
Drug discovery
Total synthesis of natural products
Heterocyclic compounds
Synthesis and functional properties of molecules
Asymmetric synthesis
Green chemistry
New reagents, strategies, catalysts and concepts for organic synthesis
Mechanistic organic chemistry
Computational chemistry
Supramolecular chemistry

Track 14: Nano medicine and Biomedical Applications

Nano medicine is simply the nanotechnology applications in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behavior of drug substances and in drug delivery. Today, nanomedicine conferences are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.

Scope of nanomedicine
Novel drugs to nano drugs
Nanomedicine for other disease
Nanomedicine for gastrointestinal tract (GI) diseases
Nanomedicine for CNS
Nanomedicine for blood disorders
Nanomedicine for lung diseases
Nanomedicine for cardiovascular diseases
Future aspects of nanomedicine
Nanodrugs for herbal medicines and cosmetics

Track 15: Chemical Synthesis and Catalysis

From drug synthesis to quality control (QC) monitoring of over-the-counter medications, metals are found in all phases of the drug development process. Many metal-based products are used as imaging agents, and metals are used in the synthesis of drug substances, as excipients in tablets, capsules and liquids. In addition, trace metals can arise from the equipment used to manufacture a drug substance or compound. Because of the prevalence of metals associated with the drug development and manufacturing process, various atomic and emission-based techniques are often used to help fully characterize pharmaceutical products.

Organocatalysis
Flow-chemistry approaches to the synthesis of key targets
Applications of organometallic compounds in synthesis and catalysis
Stereoselective synthesis
Synthesis and property of functional molecules and organic materials
Sustainable and Green synthetic and catalytic methods
Process development of key pharmaceutical targets
Synthesis in Medicinal chemistry and chemical biology
Biocatalysis in synthesis
Computational tools for synthesis and catalysis
Polymer synthesis

Track 16: Pharmacovigilance and Cosmetovigilance

Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical product. The etymological roots for the word "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Cosmetovigilance is the ongoing and systematic monitoring of the safety of cosmetics in terms of human health. The aim is to detect adverse effects of cosmetic products, and to prevent adverse effects by taking appropriate measures. Regulations for cosmetic products primarily address the safety of products that may be used by large populations of healthy consumers. The identification and analysis of adverse effects related to cosmetic products is a process that is currently still, to a large extent, industry driven. It is the responsibility of manufacturers to determine that products and ingredients are safe before they are marketed, and then to collect reports of adverse reactions.

Track 17: Bioorganic Chemistry

Broadly defined, the discipline of bioorganic chemistry seeks an understanding of biological processes through the tools and principles of organic chemistry. Bioorganic chemistry can be defined as a multifaceted field which has its historical roots in detailed mechanistic studies of enzyme along with coenzyme models. The field of bioorganic chemistry currently focuses more on the trending topics like molecular recognition, encompassing mechanistic investigations of enzymes themselves, drug design. It also deals with study of drug action, problems in biosynthesis, protein engineering, molecular evolution, supramolecular chemistry, and many other allied subjects.

Structural and in-Silico Chemistry
Chemical Biology for Drug Discovery
Pain Medications and their SAR
Recent Advances in Targeting Autophagy
Advances in Synthesis and Medicinal Chemistry
Photo-redox Catalysis

Track 18: Pharmacognosy and Phytochemistry

Phytochemistry is in the study of phytochemicals in plants and other natural sources. Phytochemicals are chemicals derived from plants. In other words the terms are often used to describe the large number of primary and secondary metabolic compounds found in plants. Phytochemicals have properties such as protection against insect attacks and diseases. They also exhibit a number of protective functions for human beings also.

Traditional Medicine
Clinical Pharmacognosy
Aromatic Medicinal Plants
Marine Drugs
Applied Plant Sciences

Track 19: Medico Marketing

Medico-Marketing focusses on exchange of drug information among drug manufacturing company and the recommending doctor, Nurse, Pharmacist or with the end user. The intention behind this data exchange is to describe the Pharmaceutical Company’s products and how it will benefit the patient community in diagnosis or management of the human ailments.

Track 20: Medicinal Chemistry: Physical Properties and Drug Design

The recent changes in the way that synthetic chemistry is practiced in this environment center around new scientific advances in synthetic techniques and modern technologies for rational drug design, combinatorial chemistry, automated synthesis, and compound purification and identification. In addition, with the beginning of high-throughput screening, we are now dealing with many targets being screened and many other hits that are being evaluated. However, success in the discovery of new drug molecules requires more and more skilled medicinal chemists to make the accurate choices with the insights gathered from interactions with computational chemists along with the insights from structural biologists, about which “hits” are likely to play out as true “lead” structures that will meet the plethora of hurdles that any drug candidate must surmount.

Virtual Screening
Target Structure-Based Design
QSAR (Quantitative Structure-Activity Relationship)
Fragment-Based Drug Design

Track 21: Recent Advances in Pharmaceutical Technology

The pharmaceutical industry channels an important proportion of total research in most developed countries. In Europe, for example, it represents about 13% of total R&D. In recent years, pharmaceutical companies have been accused of devoting their resources mainly to minor improvements over existing medications that require short clinical trials and have a small risk of not being approved. The support functions were an integral part of a large company’s R&D function but nowadays they are most likely to be outsourced under contract to external organizations specializing in a specific service, especially if these activities are not seen to offer a competitive advantage to the company. Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs).

Recent Development of Pharmaceutical Materials
Recent developments In Pharmaceutics & Biopharmaceutics
Advancements in Pharmaceutical Biotechnology
Approaches in Pharmaceutical Nanotechnology
Innovations in Pharmaceutical Technology
Advancements in Pharmaceutical Manufacturing
Development in Pharmaceutical Engineering
Pharmacological Technology advances

There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics and combinatorial chemistry for better drug candidate identification. Drug discovery has evolved significantly with emerging technologies, helping the process to become more refined, accurate, and less time consuming. Due to automation, multi-detector readers, imaging hardware and software, high-throughput screening is one of the most widely used drug discovery technologies.

In recent years, there has been a rising demand for specialty medicines that is expected to ultimately influence the small molecule drug discovery market in a positive manner, as most of the specialty medicines are small molecules.

The gradual rise in the healthcare expenditure regionally helps the new pharmaceutical technology advancement. Although with high expenditure, there is a need for redirecting the resources, the transition toward better usability of healthcare expenditure for drug development is under progress.

Scope and Importance of Pharmaceutical Sciences:

The scope of pharmacy follow includes combining and dispensing medications, and it conjointly associated with a lot of fashionable services like patient care, clinical services, reviewing medications for safety and effectivity, and conjointly providing and gaining the drug data.

A Glance at Market of Pharmaceutical Sciences:

The power of worldwide pharmaceutical company has been growing over the past year, in keeping with the annual survey conducted Worldwide. Throughout the last 10 to fifteen years, deals among the worldwide Nutrition supplements market have seen AN exceptional spike. The pharmaceutical business is a crucial player in UK. In 2017, the annual turnover of pharmaceutical product wholesalers within the United Kingdom was over forty two billion British pounds, whereas the gross sales from the retail sales of pharmaceutical product amounted to virtually 5 billion British pounds in 2015. The cost within the producing of pharmaceutical product came up to over four billion in 2019.

Growth potential

India (7.16), the U.S. (7.04) and China (6.81) are again the countries highlighted as having the fastest growth potential. Respondents viewed their high growth domestic markets and expanding manufacturing exports as a success. Germany was seen as Europe’s key growth market. The biggest movers in terms of growth potential in comparison to last year were the UK, boosting its score by 12.72%, followed by Italy (+10.94%), the U.S. (+10.63%) and Japan (+9.56%).

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 17-18, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

16^th International Conference on Pharmaceutical Chemistry August 17-18, 2020 London, UK

Recommended Global Pharmaceutical Sciences Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Pharmaceutical Chemistry-2020

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues